30 participants
An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-20
- Start Date:
- 2024-10-31
- Completion:
- 2025-08-31
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet